PlainRecalls
FDA Drug Critical Class I Terminated

Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60

Reported: July 19, 2023 Initiated: June 27, 2023 #D-0938-2023

Product Description

Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60

Reason for Recall

Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).

Details

Recalling Firm
Cipla USA, Inc.
Units Affected
278,538 canisters
Distribution
Nationwide in the US
Location
Warren, NJ

Frequently Asked Questions

What product was recalled?
Albuterol Sulfate Inhalation Aerosol, 90 mcg, 200 Metered Inhalation, net content 6.7 g canister packaged in a box, Rx only, Manufactured by: Cipla Ltd, Indore SE Z, Pithampur, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ, 07059, NDC 69097-142-60. Recalled by Cipla USA, Inc.. Units affected: 278,538 canisters.
Why was this product recalled?
Defective container: empty inhaler and leakage observed through the inhaler valve due to partially missing bottom seat (gasket).
Which agency issued this recall?
This recall was issued by the FDA Drug on July 19, 2023. Severity: Critical. Recall number: D-0938-2023.